Oncology Institute authorizes up to 5M share buyback at ≤$0.75; obtains lender consent

Oncology Institute, Inc.

Board approved repurchase of up to 5M shares of common stock at price not exceeding $0.75 per share.
Company entered Limited Consent with Deerfield to permit repurchases on or before June 16, 2023, at same price cap.
Repurchases may be made in open market or negotiated purchases; no obligation to repurchase any shares.
Limited Consent also waives certain notice requirements under the Facility Agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.